Sitagliptin combined with sulphonylureas: new indication. Other treatments are preferable.

In type 2 diabetes, sitagliptin, in combination with a sulphonylurea, only provides modest efficacy in terms of HbA1c levels and increases the risk of hypoglycaemia.